Vascular glucose sensor symposium: Continuous glucose monitoring systems (CGMS) for hospitalized and ambulatory patients at risk for hyperglycemia, hypoglycemia, and glycemic variability

Journal of Diabetes Science and Technology

Volumn 9, Issue 4, 2015, Pages 725-738

  Joseph, Jeffrey I ^a   Torjman, Marc C ^a   Strasma, Paul J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Capillary Biomedical   (United States)

Author keywords

Artificial pancreas; Continuous glucose monitor; Continuous glucose monitoring system; Glycemic variability; Hyperglycemia; Hypoglycemia; Vascular glucose sensor

Indexed keywords

AMBULATORY CARE; ARTICLE; ARTIFICIAL PANCREAS; AUTOMATION; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL OUTCOME; CONTINUOUS GLUCOSE MONITORING SYSTEM; COST; DIABETES MELLITUS; GLUCOSE SENSOR; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPLANTATION; INDWELLING CATHETER; INSULIN TREATMENT; INTRAVASCULAR CATHETER; POINT OF CARE TESTING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SAFETY; STANDARDIZATION; SUBCUTANEOUS TISSUE; ALGORITHM; ANALYSIS; BLOOD; CALIBRATION; CATHETERIZATION; DEVICES; ELECTROCHEMISTRY; EQUIPMENT DESIGN; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; IMPLANTABLE INFUSION PUMP; INSULIN INFUSION; PHYSIOLOGIC MONITORING; POINT OF CARE SYSTEM; PROCEDURES; REPRODUCIBILITY; RISK;

GLASS FIBER; GLUCOSE BLOOD LEVEL; INSULIN;

ALGORITHMS; AMBULATORY CARE; AUTOMATION; BLOOD GLUCOSE; CALIBRATION; CATHETERIZATION; DIABETES MELLITUS; ELECTROCHEMISTRY; EQUIPMENT DESIGN; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; MONITORING, PHYSIOLOGIC; OPTICAL FIBERS; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; RISK;

EID: 85018652683     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815587938     Document Type: Article

References (155)

1. Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007;30:367-369.
2. Centers for Disease Control and Prevention. Surveillance reports: reports: resource library: diabetes. http://www.cdc.gov/diabetes/library/reports/surveillance.html. Accessed December 22, 2014.
3. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-778.
4. Pomposelli J, Baxter J, Babineau T, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr. 1998;22(2):77-81.
5. Umpierrez G, Isaacs S, Bazargan N, You X, Thaler L, Kitabchi A. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
6. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-1478.
7. Vriesendorp TM, Morélis QJ, DeVries JH, Legemate DA, Hoekstra JBL. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg. 2004;28:520-525.
8. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249-2255.
9. Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001-3009.
10. Bochicchio G, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005:58(5):921-924.
11. Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty. 2010;25:64-70.
12. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction implications for patients with and without recognized diabetes. Circulation. 111;2005:3078-3086.
13. Ouattara A, Lecomte P, Le Manach Y, et al. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005;103:687-694.
14. Fischer K, Lees J, Newman J. Hypoglycemia in hospitalized patients. N Engl J Med. 1986;315:1245-1250.
15. Cryer P. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? Diabetologia. 2006;49(8):1722.
16. Krinsley J, Grover A, Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med. 2007:35(10):2262-2267.
17. Egi M, Bellomo R, Stachowski E, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Prox. 2010;85: 217-224
18. Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12): 1108-1118.
19. Vriesendorp T, De Vries J, van Santen S, et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006;34:2714-2718.
20. Kagansky N, Levy S, Rimon E, et al. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Int Med. 2003;163:1825-1829.
21. Thomas A, Boxall E, Twamley H. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2007;35(4):1218-1219.
22. Krinsley J. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008-3013.
23. Krinsley J, Egi M, Kiss A, et al. Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: an international multi-center cohort study. Crit Care 2013;17:R37.
24. Egi M, Bellomo R, Stachowski E, French C, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244-252.
25. Krinsley JS. Glycemic control in the critically ill-3 domains and diabetic status means one size does not fit all! Crit Care. 2013;17:131.
26. Furnary A, Zerr K, Grunkemeier G, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thoracic Surg. 1999;67(2):352-360.
27. Zerr K, Furnary A, Grunkemeier G, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
28. Reed CC, Stewart RM, Sherman M, et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg. 2007;204(5):1048-1054.
29. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
30. Finfer S, Chittock D, Su SYS, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
31. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5): 449-461.
32. VISEP Trial. Current controlled trials: a multi-centre, open label, randomized controlled trial of two target ranges for glycaemic control in intensive care unit (ICU) patients. Available at: http://controlled-trials.com/isrctn/trial/ISRCTN04968275/0/04969275. hlml. Accessed November 1, 2007.
33. Malberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512-1515.
34. Arabi YMM, Dabbagh OCM, Tamim HMM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190-3197.
35. Brunkhorst F. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358;125-139.
36. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233-243.
37. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-center controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the GluControl study. Intensive Care Med. 2009;35:1738-1748.
38. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663-669.
39. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251-3276.
40. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16-38.
41. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32:1119-1131.
42. Joshi GP, Chung F, Vann MA, et al. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010;111:1378-1387.
43. Finfer S, Wernerman J, Preiser JC, et al. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care. 2013;17:229.
44. Kavanagh BP. Glucose in the ICU-evidence, guidelines, and outcomes. N Engl J Med. 2012;367:1259-1260.
45. Malhotra A. Intensive insulin in intensive care. N Engl J Med. 2006;354(5):516-518.
46. Clement S, Braithwaite S, Magee M, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004:27:553-591.
47. Clement S. Better glycemic control in the hospital: beneficial and feasible. Cleve Clin J Med. 2007;74(2):111-120.
48. Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:49-58.
49. Joseph J. Management of the Diabetic Surgical Patient, Textbook of Type 2 Diabetes. Valley Stream, NY: Martin Dunitz; 2007.
50. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15:370-377.
51. Kulkarni A, Saxena M, Price G, O'Leary MJ, Jacques T, Myburgh JA. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med. 2005;31:142-145.
52. Karon BS, Gandhi GY, Nuttall GA, et al. Accuracy of Roche Accu-Chek Inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol. 2007;127(6):919-926.
53. Flood J, Joseph J, Kim L, McNulty S, Chervoneva I. Glucose levels in blood simultaneously sampled from the radial artery, vena cava, and fingertip. Paper presented at: American Society Anesthesiology; October 2007; San Francisco, CA.
54. Nayak PP, Morris K, Lang H, et al. Lack of agreement between arterial and central venous blood glucose measurement in critically ill children. Intensive Care Med. 2009;35(4):762-763.
55. Food and Drug Administration. Adverse event report November 12, 1997. VIA01 glucose monitoring system. www. fda.gov. Accessed November 1, 2007.
56. Kuwa K, Nakayama T, Hoshino T, Tominaga M. Relationships of glucose concentrations in capillary whole blood, venous whole blood, and venous plasma. Clin Chim Acta. 2001;307:187-192.
57. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-409.
58. Fahy BG, Coursin DB. Critical glucose control: the devil is in the details. Mayo Clin Proc. 2008;83(4):394-397.
59. Finkielman JD, Oyen LJ, Afessa B. Agreement between bedside blood and plasma glucose measurement in the ICU setting. Chest. 2005;127(5):1749-1751.
60. Slater-MacLean L, Cembrowski G, Chin D, et al. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther. 2008;10(3):169-177.
61. Desachy A, Vuagnat AC, Ghazali AD, et al. Accuracy of bedside glucometry in critically ill patients: influence of clinical characteristics and perfusion index. Mayo Clin Proc. 2008;83(4):400-405.
62. Sylvain HF, Pokorny ME, English SM, et al. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995;4(1):44-48.
63. Sacks D, Bruns D, Horton J, et al. Clinical Laboratory Standards Institute. POCT12-A3: Point-of-care blood glucose testing in acute and chronic care facilities; approved guideline-third edition. January 2013.
64. Wernerman J, Desaive T, Finfer S, et al. Continuous glucose control in the ICU: report of a 2013 round table meeting. Crit Care. 2014;18:226.
65. Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol. 2009;3(6):1309-1318.
66. Weiss R, Lazar I. The need for continuous blood glucose monitoring in the intensive care unit. J Diabetes Sci Technol. 2007;1(3):412-414.
67. Inzucchi S, Kosiborod M. Continuous glucose monitoring during critical care. Anesthesiology. 2011;114(1):18-19.
68. Martinez E, Williams K, Pronovost P. Thinking like a pancreas: perioperative glycemic control. Anesth Analg. 2007;104(1): 4-6.
69. Torjman MC, Goldberg ME, Hirsh RA, Littman J. Thinking like a pancreas: a look ahead at diabetes technology in the perioperative setting. Anesth Analg. 2007;105(2):545.
70. Mraovic B. Analysis: continuous glucose monitoring during intensive insulin therapy. J Diabetes Sci Technol. 2009;3(4):960-963.
71. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients a prospective randomized trial. Diabetes Care. 2010;33:467-472.
72. Ryan M, Savarese V, Hipszer B, et al. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther. 2009;11(11):745-747.
73. Piper HG, Alexander JL, Shukla A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery. Pediatrics. 2006;118(3):1176-1184.
74. Krinsley J. Is glycemic control of the critically ill cost-effective? Hosp Pract. 2014;42:4.
75. Scurlock C, Raikhelkar J, Mechanick JI. The economics of glycemic control in the ICU in the United States. Curr Opin Clin Nutr Metab Care. 2011;14:209-212.
76. Van den Berghe G, Wouters P, Kestesteloot K, Hilleman DE, Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34(3):612-616.
77. Zijlstra JG, Corstjens AM, Tulleken JE, Meertens JH, Ligtenberg JJ. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;130(6):1953-1954.
78. Krinsley J, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644-650.
79. Signal M, Pretty CG, Chase JG, Le Compte A, Shaw GM. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol. 2010;4(3):625-635.
80. Boom DT, Sechterberger MK, Rijkenberg S, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014;18:453.
81. Agus MS, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367:1208-1219.
82. Vriesendorp TM, DeVries JH, Holleman F, et al. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther. 2005;7:315-322.
83. Wintergerst KA, Deiss D, Buckingham B, et al. Glucose control in pediatric intensive care unit patients using an insulinglucose algorithm. Diabetes Technol Ther. 2007;9(3):211-222.
84. Kopeck P, Mráz M, Bláha J, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardio-surgical ICU. BioMed Res Int. 2013:186439. http://dx.doi.org/10.1155/2013/186439.
85. Chee F, Fernando T, van Heerden PV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care. 2002;30(3):295-307.
86. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically-ill patients using continuous glucose monitoring system (CGMS) in real-time. IEEE Trans Info Technol Biomed. 2003;7:43-53.
87. Chase JG, Shaw GM, Lin J, et al. Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther. 2005;7(2):274-282.
88. Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control utilizing continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17:R159.
89. Logtenberg S, Kleefstra N, Snellen F, et al. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther. 2009;11:31-37.
90. De Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29:1750-1756.
91. Brunner R, Kitzberger R, Miehsler W, Herkner H, Madl C, Holzinger U. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011;39:659-664.
92. Price GC, Stevenson K, Walsh TS. Evaluation of a continuous glucose monitor in an unselected general intensive care population. Crit Care Resusc. 2008;10(3):209-216.
93. Rabiee A, Virginia Andreasik RN, Abu-Hamdah R, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabetes Sci Technol. 2009;3(4):951-959.
94. Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6(3):339-347.
95. Vriesendorp TM, DeVries JH, Holleman F, Dzoljic M, Hoekstra JB. The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther. 2005;7(2): 315-322.
96. Coss-Bu JA, Jefferson LS, Stone-McCord S, et al. Evaluation of a real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract. 1999;44(3):175-181.
97. Allen HF, Rake A, Roy M, Brenner D, McKiernan CA. Prospective detection of hyperglycemia in critically ill children using continuous glucose monitoring. Pediatr Crit Care Med. 2008;9(2):153-158.
98. Holzinger U, Warszawska J, Kitzberger R, et al. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med. 2009;35:1383-1389.
99. Corstjens AM, Ligtenberg JJM, Van der Horst ICC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analyses in critically ill ICU patients. Crit Care. 2006;10(5):R135.
100. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients. Diabetes Care. 2010;33:467-472.
101. Hipszer B, Joseph JI. Lag associated with interstitial glucose sensors used in a diabetic surgical patient. Anesthesiology. 2006;105:A584.
102. Kosiborod M, Gottlieb RK, Sekella JA, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Care. 2014;2.
103. Kagel E, Rayan G. Intravenous catheter complications in the hand and forearm. J Trauma. 2004;56(1):123-127.
104. Colman R, Marder V, Salzman E, Hirsh J. Overview of hemostasis. In: Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: J.B. Lippincott; 1994:3-18.
105. Turritto VT, Baumgartner HR. Initial deposition of platelets and fibrin on vascular surfaces in flowing blood. In: Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: J.B. Lippincott; 1994:805-822.
106. Leonard E. Rheology of thrombosis. In: Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: J.B. Lippincott; 1994:1211-1223
107. Salzman E, Merrill E, Kent C. Interaction of blood with artificial surfaces. In: Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: J.B. Lippincott; 1994:1469-1485.
108. Joseph JI, Hipszer B. Real-time glucose monitoring in the hospital: future or now? Adv Surg. 2010;44:165-184.
109. Ganesh A, Hipszer B, Loomba N, Torjman MC, Joseph J. Evaluation of the VIA blood chemistry monitor for glucose in healthy and diabetic volunteers. J Diabetes Sci Technol. 2008;2(2):182-193.
110. Bailey P, McJames S, Cluff M, Wells D, Orr J, Wenternskow D. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor. J Clin Monit Comput. 1998;14:339-346.
111. Lucisano JY, Edelman SV, Quinto BD, Wong DK. Development of a biosensor-based, patient-attached blood glucose monitoring system. Proc Am Chem Soc. 1997;76:256.
112. Foubert L, Lecomte P, Nobels F, Gulino A, De Decker K. Accuracy of a feasibility version of an intravenous continuous glucose monitor in volunteers with diabetes and hospitalized patients. Diabetes Technol Ther. 2014;16:858-866.
113. Joseph J, Hipszer B, Grunwald Z, et al. Performance of an automated blood glucose monitor in the OR-ICU. Paper presented at: American Society of Anesthesiology; October 2009; New Orleans, LA.
114. Bochicchio G, Hipszer B, Magee M, et al. Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients. J Diabetes Sci Technol. 2015;9:739-750.
115. Bailey T, Gulino A, Higgins M, Leach J, Kamath A, Simpson P. Accuracy of a first-generation intravenous blood glucose monitoring system in subjects with diabetes mellitus: a multicenter study. J Diabetes Sci Technol. 2013;7(6):1484-1491.
116. Van Hooijdonk R, Winters T, Fischer J, et al. Accuracy and limitations of continuous glucose monitoring using spectroscopy in critically ill patients. Ann Intensive Care. 2014;4:8.
117. Krinsley J, Bochicchio K, Calentine C, Bochicchio G. Glucose measurement of intensive care unit patient plasma samples using a fixed-wavelength mid-infrared spectroscopy system. J Diabetes Sci Technol. 2012;6:294-301.
118. Jax T, Heise T, Nosek L, Gable J, Lim G, Calentine C. Automated near- continuous glucose monitoring measured in plasma using mid-infrared spectroscopy. J Diabetes Sci Technol. 2011;5:345-352.
119. Umbrello M, Salice V, Spanu P, et al. Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device. Clin Nutr. 2014;33:867-871.
120. Kunjan K, Lloyd P. Automated blood sampling and glucose sensing in critical care settings. J Diabetes Sci Technol. 2008;2(2):194-200.
121. Schierenbeck F, Franco-Cereceda A, Liska J. Evaluation of a continuous blood glucose monitoring system using central venous micro dialysis. J Diabetes Sci Technol. 2012;6(6):1365-1371.
122. Moller F, Liska J, Eidhagen F, Franco-Cereceda A. Intravascular microdialysis as a method for measuring glucose and lactate during and after cardiac surgery. J Diabetes Sci Technol. 2011;5(5):1099-1107.
123. Schierenbeck F, wall A, Franco-Cereceda A, Liska J. Evaluation of a continuous blood glucose monitoring system using a central venous catheter with an integrated micro dialysis function. Diabetes Technol Ther. 2013;15(1):26-31.
124. Schierenbeck F, Nijsten MWN, Franco-Cereceda A, Liska J. Introducing intravascular microdialysis for continuous lactate monitoring in patients undergoing cardiac surgery: a prospective observational study. Crit Care. 2014;18(2):R56.
125. Schierenbeck F, Wallin M, Franco-Cereceda A, Liska J. Evaluation of intravascular microdialysis for continuous blood glucose monitoring in hypoglycemia: an animal model. J Diabetes Sci Technol. 2014;8:839-844.
126. Prasad M, Gopal P, Mannam G. Continuous monitoring of blood glucose using a fiberoptic-based intravascular sensor during postoperative care in the ICU. Crit Care. 2014;18(suppl 1):442.
127. Crane B, Barwell N, Jones C, Mackenzie A, Mulavisala KP. The Development of a Continuous Intravascular Glucose Monitoring Sensor. J Diabetes Sci Technol. 2015; 9: 751-761.
128. Strasma P, Finfer S, Flower O, et al. Use of an Intravascular Fluorescent Continuous Glucose Sensor in ICU Patients. J Diabetes Sci Technol. 2015;9:762-770.
129. Machado P, Liu JB, Hipszer B, et al. Use of ultrasound to monitor blood flow and thrombus formation around a radial artery catheter and intravascular glucose sensor in surgical patients, Paper presented at: American Institute of Ultrasound in Medicine; March 29-April 2, 2014; Las Vegas, NV.
130. Peyser T, Zisser H, Khan U, et al. Use of a novel fluorescent glucose sensor in volunteer subjects with type 1 diabetes mellitus. J Diabetes Sci Technol. 2011;5(3):687-693.
131. Romey M, Jovanovič L, Bevier W, Markova K, Strasma P, Zisser H. Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus. J Diabetes Sci Technol. 2012;6(6):1260-1266.
132. Flower OJ, Bird S, Macken L, et al. Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing: a product development study. Crit Care Resusc. 2014;16(1):54-61.
133. Skjaervold N, Sollig S, Hjelme DR, Asadahl P. Continuous measurement of blood glucose. Anesthesiology. 2011;114:120-125.
134. Skjaervold N, stling D, Hjelme D, Spigset O, Lyng O, Aadahl P. Blood glucose control using a novel continuous blood glucose monitor and repetitive intravenous insulin boluses: exploiting natural insulin pulsatility as a principle for a future artificial pancreas. Int J Endocrinol. 2013;2013:245152.
135. Kadish AH. A servomechanism for blood sugar control. Biomed Sci Instrum. 1963;1:171-176.
136. Kadish AH. Automation control of blood sugar: a servomechanism for glucose monitoring and control. Am J Med Electron. 1964;3:82-86.
137. Clemens AH, Chang PH, Myers RW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS). Horm Metab Res. 1977;7(suppl):23-33.
138. Albisser AM, Leibel BS, Ewart TF, et al. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974;23(5): 397-404.
139. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg. 2008;106(1):160-163.
140. Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in postsurgical patients. Acta Anaesthesiol Scand. 2009;53(1):66-71.
141. Ozyol MB, Herfarth C, Kerner W, Pfeiffer EF. Postoperative blood-sugar regulation in pancreatectomized patients using the artificial "beta cell." Chirurg. 1979;50(4):227-232.
142. Gin H, Catargi B, Rigalleau V, Rullier E, Roger P, Tabarin A. Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas. Eur J Endocrinol. 1998;139(4):371-377.
143. Okabayashi T, Hnazaki K, Nishimori I, et al. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci. 2008;53(5):1405-1410.
144. Takahashi G, Sato N, Matsumoto N, et al. Preliminary study on glucose control with an artificial pancreas in postoperative sepsis patients. Eur Surg Res. 2011;47:32-38.
145. Maeda H, Okabayashi T, Yatabe T, Yamashita K, Hanazaki K. Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy. World J Gastroenterol. 2009;15(33):4111-4115.
146. Joseph JI, Torjman MC. Implantable glucose sensors. In: Wnek G, Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering. New York, NY: Marcel Dekker; 2004:683-692.
147. Brockway R, Tiesma S, Bogie H, et al. Fully Implantable Arterial Blood Glucose Device for Metabolic Research Applications in Rats for Two Months. J Diabetes Sci Technol. 2015; 9:771-781.
148. Tiesma S, Brockway R, Coskun T, O'Farrell L, Michael MD, Cox A. Assessment of insulin response in STZ rats using continuous glucose telemetry. Paper presented at: American Diabetes Association; June 15, 2014; Alexandria, VA.
149. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes. 1990;39(12):1519-1526.
150. Renard E, Costalat G, Chevassus H, Bringer J. Artificial betacell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 2006;32:497-502.
151. Renard E, Costalat G, Chevassus H, Bringer J. Artificial beta cell: clinical experience toward an implantable closedloop insulin delivery system. Diabetes Metab. 2006;32(5 pt 2):497-502.
152. Crothall K, Joseph J, Torjman M, et al. Development of an implantable NIR spectroscopic blood glucose sensor: invivo results in dogs. Paper presented at: American Diabetes Association; June 1999; San Diego, CA.
153. Joseph J, Torjman MC, Moritz M, Destephano M. Long-term implantable optical blood glucose sensor. Paper presented at: Association of Chemical Engineering; 2000; Boston, MA .
154. Joseph J, Destephano M, Torjman MC, Moritz M, Crothall K, Jahn L. Development of an implantable optical glucose sensor. Paper presented at: Pittsburgh Conference; 2001; Pittsburgh, PA.
155. Yu Y, Crothal K, Jahn L, DeStefano M. Laser diode applications in a continuous blood glucose sensor. Proc SPIE. 2003;4996:268-274.